Tag: medical

Medical Marketing Agency: Innovating Healthcare

by  on  in Advertising & Marketing

Houston, Dec. 26, 2023 (GLOBE NEWSWIRE) — Houston, Texas –

Medical marketing agencies can be a game-changer, reshaping how doctors and plastic surgeons attract new patients, according to Doctor Marketing, MD™. In the fast-paced world of healthcare, a results-driven medical marketing agency will leverage proven strategies that not only highlight cosmetic procedures, but also build a trustworthy brand image around the key doctors and surgeons. Medical marketing isn’t just another form of advertising, it blends distinctive concepts and approaches specifically designed for the healthcare sector.

Image Credit: Lenetstan / 123RF.

“It’s advertising without looking or feeling like advertising. By prioritizing high-quality written medical content creation such as influential blog posts and informative articles on a doctor or plastic surgeon’s website, our agency has developed a unique strategy that combines in-depth medical insights with engaging storytelling. This approach not only increases a doctor’s online presence in Google, but also significantly improves their patient understanding and engagement by simplifying complex medical topics,” said Marty Stewart, Chief Marketing Officer (CMO) of Doctor Marketing, MD™.

Doctor Marketing, MD™ helps Medical Professionals and Healthcare Providers to get more patients by increasing patient acquisition through strategically leveraged content that ranks high in Google. This strategic form of doctor marketing is genuine and authentic, and focuses on what a patient is already typing into a Google search.

The healthcare industry has undergone massive changes in recent years. With the rise of consumerism and access to information, patients are more empowered than ever when making choices about their health. This shift has forced healthcare providers to rethink their approach to patient acquisition and retention. Simply being a competent physician or surgeon is no longer enough. Healthcare professionals must effectively communicate their value and market their services.

This is where a specialized medical marketing agency can make a dramatic

… Read More ...

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

by  on  in Business Financial News

EMERYVILLE, Calif., August 14, 2023–(BUSINESS WIRE)–Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today reported financial results for the second quarter of 2023 and provided a business update.

Vivani™ continues to advance its emerging portfolio of innovative, highly differentiated drug implants leveraging its proprietary NanoPortal™ subdermal implant technology designed to guarantee medication adherence and improve patient outcomes in the treatment of chronic diseases. Vivani’s lead therapeutic candidate, NPM-119, is a miniature, six-month, GLP-1 implant using NanoPortal technology.

“At Vivani, we are continuing our progression from a preclinical to clinical-stage biopharmaceutical company. As planned, we have successfully completed the production of clinical trial materials and submitted our Investigational New Drug (IND) application for NPM-119 (exenatide implant) in July. Although we received verbal notification from the U.S. Food and Drug Administration (FDA) that our NPM-119 IND will be placed on clinical hold, we await the receipt of FDA’s comments and intend to respond to the agency’s requests with the goal of achieving IND clearance and proceeding with our plans to initiate the proposed first-in-human, Phase 2 clinical study of NPM-119 named LIBERATE-1™,” said Adam Mendelsohn, Ph.D., Vivani’s President and Chief Executive Officer. “LIBERATE-1 represents the first clinical application of our NanoPortal technology and is designed to evaluate the safety, tolerability and full pharmacokinetic profile of NPM-119 compared to an active control group. The study will also evaluate glycemic control and weight-loss information and we aim to better understand the translation of drug release profiles from our animal models to patients with type 2 diabetes which will inform the development of NPM-119 and our emerging portfolio of long-term drug implants with the potential to revolutionize chronic disease treatments.”

Second Quarter Business Highlights

In early July 2023,

… Read More ...

KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates

by  on  in Business Financial News

MAHWAH, N.J., August 02, 2023–(BUSINESS WIRE)–KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced preliminary unaudited revenues for the second quarter 2023 and provided business, outlook and executive updates.

The Company reported total net revenues for the second quarter 2023 of approximately $6.9 million, representing growth of approximately 6% compared to the prior year period. Domestic Core revenues increased approximately 8%, International Core revenues increased approximately 17%, and Novel Therapies revenues declined approximately 28% compared to the prior year period.

Full year 2023 net revenues are now expected to be between $31 million and $32.5 million, representing revenue growth in the range of 11%-17% from the prior year. The Company’s guidance for full year 2023 has been updated to reflect a Q2 2023 decline in the U.S. subcutaneous immunoglobulin market, resulting in a change of KORU Medical’s outlook on underlying U.S core market growth assumption from 10% to the mid-single digit range. In addition, the Company’s guidance reflects a change in timing of Novel Therapies revenues.

The Company’s cash balance was $11.7 million as of June 30, 2023, and it is reaffirming an expected end of year cash balance greater than $10.0 million and full year gross margin between 58-60%, and 60-62% exit rate.

“I am pleased our U.S. revenue growth significantly exceeded the overall U.S. market in the quarter and we saw continued strength in our international business,” said Linda Tharby, KORU Medical’s President and CEO. “The foundation of our business remains sound, and we see continued progress this quarter in Novel Therapies collaborations, with a new deal being signed and the early submission

… Read More ...

Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023

by  on  in Business Financial News
Nemaura Medical, Inc

Nemaura Medical, Inc

Loughborough, England, July 14, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today provides a business update and financial results for the fiscal year ended March 31, 2023.

Corporate Highlights:

 

 

  • Entered into a Registered Direct Offering and concurrent Private Placement for gross proceeds of approximately $8.4 million (before expenses).

  • Signed a preliminary agreement with Eversana to support a planned commercial launch of its Diabetes and Metabolic Health programs in the USA.

  • Announced initial patient data from UK NHS (National Health Service) Miboko Study that thus far demonstrated weight loss in 100% of participants, with further studies ongoing. The data is expected to support reimbursement applications and product marketing in various territories.

  • Continued to work with Benchmark Electronics Inc as a contract manufacturing partner (CMO) to facilitate future volume scale-up manufacture of the electronic transmitter at its FDA approved facility in Thailand, in anticipation of commercial-sales ramp-up.

  • Completed phased delivery of transmitters against the purchase order received from MSW in December 2021.

  • Received a provisional purchase order for 1.7 million sensors from its licensee TPMENA in anticipation of product registration in the KSA.

“We continue to build momentum on both manufacturing activities and consumer feedback through pilot trials, in preparation for scaling up commercial sales activities. The trials with the NHS in the UK have demonstrated the commercial potential for our sensors and digital health and wellbeing programs and has allowed us to undertake continuous refinements prior to commercial scale-up initiatives. Similarly, we believe working with world-class contract manufacturers and advancing our manufacture scale-up, and ensuring a well-managed supply chain through forward planning will support our planned commercial endeavours”, commented Dr Faz

… Read More ...

How To Write A Healthcare Or Medical Business Proposal

by  on  in Business Investment News

BusinessAt the moment foreign businesses in joint ventures with regional firms are allowed to import a restricted variety of products such as fertilizers, pesticides, construction supplies and automobiles but only organizations in the manufacturing sector are allowed to export. Your sunk investment contains all expenses that you have to bear out of pocket until your business reaches cash flow breakeven. When you plan for what it actually requires to be successful actions can be taken to start at a manageable scale and then develop as sales boost and you improve operations. YouTube videos usually spot quite higher in search engine rankings so concentrate it to your business and your nearby location.

Therefore, make positive you create your business apology letter honestly and with suitable care, unless you want to finish up undertaking more damage than you already did. These suggestions will prove to be extremely beneficial for nay individual who is willing to start off a business in a tiny amount. You can always verify with an lawyer if you have any legal concerns about beginning your own business. Owning and operating your personal craft business will leave you in manage to do what you believe is proper for your business and see it develop. Beginning a business is pricey adequate, so here’s some entirely cost-free software program that can support you handle your business. This website and its tools make use of an all hazards approach” and follows the plan elements within National Fire Protection Association 1600 , Standard on Disaster/Emergency Management and Business Continuity Applications. If your item falls inside these three categories, then you will be in business in no time!

Understanding the approach and structure of firms forms a crucial element of the discipline of business history, as does the deployment of crucial tools such as … Read More ...